Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.825
-0.054 (-6.14%)
Apr 29, 2026, 10:17 AM EDT - Market open
RVPH Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -19.86 | -29.92 | -39.26 | -28.26 | -8.52 | |
| Stock-Based Compensation | 2.23 | 1.63 | 3.41 | 0.18 | 0.15 | |
| Other Operating Activities | -0.09 | -0.72 | 0.24 | 0.19 | -1.59 | |
| Change in Accounts Payable | -3.41 | 2.29 | 0.33 | 3.01 | -0.5 | |
| Change in Other Net Operating Assets | -3.46 | -6.83 | 6.96 | 5.92 | -0.2 | |
| Operating Cash Flow | -24.59 | -33.54 | -28.32 | -18.96 | -10.67 | |
| Short-Term Debt Issued | 0.41 | 0.98 | 0.67 | - | - | |
| Total Debt Issued | 0.41 | 0.98 | 0.67 | - | - | |
| Short-Term Debt Repaid | -0.46 | -0.52 | -0.67 | - | - | |
| Total Debt Repaid | -0.46 | -0.52 | -0.67 | - | - | |
| Net Debt Issued (Repaid) | -0.05 | 0.46 | - | - | - | |
| Issuance of Common Stock | 25.61 | 23.19 | 33.17 | 7.79 | 31.6 | |
| Financing Cash Flow | 25.56 | 23.65 | 33.17 | 7.79 | 31.6 | |
| Net Cash Flow | 0.96 | -9.89 | 4.85 | -11.17 | 20.93 | |
| Cash Interest Paid | 0.01 | 0.02 | 0.03 | - | - | |
| Cash Income Tax Paid | 0 | 0 | 0.02 | - | 0 | |
| Levered Free Cash Flow | -17.14 | -21.54 | -14.01 | -8.54 | -6.87 | |
| Unlevered Free Cash Flow | -17.13 | -21.52 | -13.99 | -8.54 | -6.87 | |
| Change in Working Capital | -6.87 | -4.54 | 7.28 | 8.93 | -0.7 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.